Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.77 USD | +1.85% | +2.38% | -47.40% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 10M | Capitalization | 353M |
---|---|---|---|---|---|
Net income 2024 * | -71M | Net income 2025 * | -86M | EV / Sales 2024 * | - |
Net cash position 2024 * | 311M | Net cash position 2025 * | 430M | EV / Sales 2025 * | -7.65 x |
P/E ratio 2024 * |
-4.68
x | P/E ratio 2025 * |
-4.54
x | Employees | 44 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 77.39% |
Latest transcript on Tourmaline Bio, Inc.
1 day | +1.85% | ||
1 week | +2.38% | ||
1 month | -13.01% | ||
3 months | -64.53% | ||
6 months | -26.56% | ||
Current year | -47.40% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 17 M€ | +4.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 13.77 | +1.85% | 273,405 |
24-05-30 | 13.52 | -0.66% | 695,090 |
24-05-29 | 13.61 | -0.66% | 273,065 |
24-05-28 | 13.7 | +1.86% | 430,638 |
24-05-24 | 13.45 | -1.54% | 326,966 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.40% | 347M | |
+11.91% | 114B | |
+11.60% | 105B | |
-4.68% | 23.83B | |
-0.82% | 21.73B | |
-10.12% | 18.1B | |
-42.12% | 16.34B | |
-17.47% | 16.13B | |
+2.77% | 13.75B | |
+34.58% | 11.76B |
- Stock Market
- Equities
- TRML Stock